Chang HM - Search Results

1

FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.

Yoo C, Hwang I, Song TJ, Lee SS, Jeong JH, Park DH, Seo DW, Lee SK, Kim MH, Byun JH, Park JH, Hwang DW, Song KB, Lee JH, Lee W, Chang HM, Kim KP, Kim SC, Ryoo BY. Yoo C, et al. Among authors: chang hm. Ther Adv Med Oncol. 2020 Sep 16;12:1758835920953294. doi: 10.1177/1758835920953294. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32983266 Free PMC article.

2

Locally advanced acinar cell carcinoma of the pancreas successfully treated by capecitabine and concurrent radiotherapy: report of two cases.

Lee JL, Kim TW, Chang HM, Lee SK, Kim MH, Kang YK, Kim JS, Kim JH. Lee JL, et al. Among authors: chang hm. Pancreas. 2003 Jul;27(1):e18-22. doi: 10.1097/00006676-200307000-00019. Pancreas. 2003. PMID: 12826914 No abstract available.

3

Capecitabine in combination with Oxaliplatin (XELOX) as a first-line therapy for advanced gastric cancer.

Park YH, Lee JL, Ryoo BY, Ryu MH, Yang SH, Kim BS, Shin DB, Chang HM, Kim TW, Yuh YJ, Kang YK. Park YH, et al. Among authors: chang hm. Cancer Chemother Pharmacol. 2008 Apr;61(4):623-9. doi: 10.1007/s00280-007-0515-7. Epub 2007 May 24. Cancer Chemother Pharmacol. 2008. PMID: 17522863 Clinical Trial.

4

Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea.

Yoo C, Ryu MH, Huh J, Park JH, Kang HJ, Ahn HS, Lee Y, Kim MJ, Lee H, Kim TW, Chang HM, Lee JL, Kang YK. Yoo C, et al. Among authors: chang hm. Am J Hematol. 2007 Sep;82(9):821-3. doi: 10.1002/ajh.20962. Am J Hematol. 2007. PMID: 17570512 Free article.

5

Efficacy and safety of S-1 monotherapy in patients with advanced biliary tract adenocarcinoma: retrospective analysis of 162 patients.

Park I, Lee JL, Ryu MH, Kim TW, Chang HM, Lee SS, Sohn BS, Kim EK, Park DH, Lee SS, Suh DW, Lee SK, Kim MH, Lee J. Park I, et al. Among authors: chang hm. Oncology. 2009;76(2):126-32. doi: 10.1159/000195538. Epub 2009 Jan 22. Oncology. 2009. PMID: 19158445

6

A prospective, multicenter, phase 2 study of imatinib mesylate in korean patients with metastatic or unresectable gastrointestinal stromal tumor.

Ryu MH, Kang WK, Bang YJ, Lee KH, Shin DB, Ryoo BY, Roh JK, Kang JH, Lee H, Kim TW, Chang HM, Park JO, Park YS, Kim TY, Kim MK, Lee WK, Kang HJ, Kang YK. Ryu MH, et al. Among authors: chang hm. Oncology. 2009;76(5):326-32. doi: 10.1159/000209384. Epub 2009 Mar 23. Oncology. 2009. PMID: 19307738 Clinical Trial.

7

EC-18, a synthetic monoacetyldiacylglyceride, inhibits hematogenous metastasis of KIGB-5 biliary cancer cell in hamster model.

Kim MH, Chang HM, Kim TW, Lee SK, Park JS, Kim YH, Lee TY, Jang SJ, Suh CW, Lee TS, Kim SH, Lee SG. Kim MH, et al. Among authors: chang hm. J Korean Med Sci. 2009 Jun;24(3):474-80. doi: 10.3346/jkms.2009.24.3.474. Epub 2009 Jun 12. J Korean Med Sci. 2009. PMID: 19543512 Free PMC article.

8

Phase I/II and pharmacokinetic study of S-1 and oxaliplatin in previously untreated advanced gastric cancer.

Park I, Lee JL, Ryu MH, Chang HM, Kim TW, Sym SJ, Lee SS, Jang G, Yoo C, Bae KS, Kang YK. Park I, et al. Among authors: chang hm. Cancer Chemother Pharmacol. 2010 Feb;65(3):473-80. doi: 10.1007/s00280-009-1052-3. Epub 2009 Jun 24. Cancer Chemother Pharmacol. 2010. PMID: 19551382 Clinical Trial.

9

Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.

Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK. Sym SJ, et al. Among authors: chang hm. Ann Surg Oncol. 2010 Apr;17(4):1024-32. doi: 10.1245/s10434-009-0838-1. Epub 2009 Nov 26. Ann Surg Oncol. 2010. PMID: 19941081 Clinical Trial.

10

A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer.

Kim C, Lee JL, Ryu MH, Chang HM, Kim TW, Lim HY, Kang HJ, Park YS, Ryoo BY, Kang YK. Kim C, et al. Among authors: chang hm. Invest New Drugs. 2011 Apr;29(2):366-73. doi: 10.1007/s10637-009-9363-0. Epub 2009 Dec 9. Invest New Drugs. 2011. PMID: 19997960 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

842 results

Search Page